Revised Grassley, Wyden drug pricing bill more patient- and pharma-friendly

Sens. Chuck Grassley (R-Iowa) and Ron Wyden (D-Ore.) Friday released a revised version of the Prescription Drug Pricing Reduction Act of 2019 that includes changes that would help Medicare beneficiaries and the biopharmaceutical industry.

The bill retains provisions the industry opposes that would cap Medicare Part D drug price increases at the level of consumer inflation.

The White House reiterated its support for PDPRA Friday.

Read the full 655 word article

User Sign In